Patents by Inventor David Sinclair

David Sinclair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10470987
    Abstract: Compositions allowing the stimulation of hyaluronic acid synthesis via an increase in has-2 expression and their use in the treatment of conditions related to a decrease in hyaluronic acid synthesis.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: November 12, 2019
    Assignees: TOMCAT INTERNATIONAL LIMITED, President and Fellows of Harvard College
    Inventors: Bertrand Thomas, Mathilde Thomas, David Sinclair
  • Publication number: 20190314395
    Abstract: The invention relates to modulation of SIRT3 activity levels. The invention has applications for regulating metabolism and mimicking caloric restriction or exercise in a muscle cell.
    Type: Application
    Filed: June 27, 2018
    Publication date: October 17, 2019
    Applicant: President and Fellows of Harvard College
    Inventors: David A. Sinclair, Juan Carmona
  • Publication number: 20190313080
    Abstract: Systems, methods, and articles of manufacture are disclosed that enable the compression of depth data and real-time reconstruction of high-quality light fields. In one aspect, spatial compression and decompression of depth images is divided into the following stages: generating a quadtree data structure for each depth image captured by a light field probe and difference mask associated with the depth image, with each node of the quadtree approximating a corresponding portion of the depth image data using an approximating function; generating, from the quadtree for each depth image, a runtime packed form that is more lightweight and has a desired maximum error; and assembling multiple such runtime packed forms into per-probe stream(s); and decoding at runtime the assembled per-probe stream(s). Further, a block compression format is disclosed for approximating depth data by augmenting the block compression format 3DC+(BC4) with a line and two pairs of endpoints.
    Type: Application
    Filed: September 21, 2018
    Publication date: October 10, 2019
    Inventors: Kenneth J. MITCHELL, Charalampos KONIARIS, Malgorzata E. KOSEK, David A. SINCLAIR
  • Publication number: 20190110481
    Abstract: Provided herein are secretory compositions/cocktails derived from a novel, extremophilic fungal species cultured, isolated, characterized and sequenced herein. Said novel, extremophilic fungal species may be exploited to produce a secretory compositions/cocktails which comprise a unique mixture of thermo-tolerant, stable enzymes capable of digesting cellular and genetic material in its surroundings under extreme temperatures. Such secretory compositions/cocktails may be useful as cleaning and sterilization solutions against biofilm, urine, yeast, bacterial, or viral contamination. Other uses include, but are not limited to, urea removal, fertilizer wastewaters, wastewater reclamation for life support systems in space, pH control, source of ammonia and carbon dioxide, starch digestion, biofuel production, as pharmaceuticals, and medical treatments such as wounds, skin disorders, or nail disorders.
    Type: Application
    Filed: April 5, 2017
    Publication date: April 18, 2019
    Inventors: David A. Sinclair, Kyle S. Landry
  • Publication number: 20190093140
    Abstract: Enzyme-based systems and methods for synthesizing the NAD precursors NMN and NaMN are disclosed. Such methods and systems utilize a mutated form of phosphoribosylpyrophosphate synthetase (PRS) that is superactive and/or other enzyme or enzyme combinations that are immobilized onto a solid surface. The methods and systems substantially increase the efficiency and yield of NAD precursor synthesis.
    Type: Application
    Filed: June 8, 2016
    Publication date: March 28, 2019
    Inventors: Lindsay Wu, David A. Sinclair, Kyle Meetze
  • Patent number: 10229215
    Abstract: A method of rendering content items on a display via an electronic device involves mapping linked content items to a three-dimensional object defined by layout data. The layout data is then transmitted to an electronic device for display.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: March 12, 2019
    Assignees: DISNEY ENTERPRISES, INC., ETH ZÜRICH (EIDGENÖSSISCHE TECHNISCHE HOCHSCHULZE ZÜRICH)
    Inventors: Barbara Solenthaler, Sohyeon Jeong, Max Grosse, Sasha Schriber, David Sinclair, Maria Cabral, Markus Gross, Kenneth J. Mitchell
  • Publication number: 20190002919
    Abstract: In vivo methods using bioenergetic agents for restoring the quality of aged oocytes, enhancing oogonial stem cells or improving derivatives thereof (e.g., cytoplasm or isolated mitochondria) for use in fertility-enhancing procedures, are described.
    Type: Application
    Filed: July 13, 2018
    Publication date: January 3, 2019
    Inventors: Jonathan L. Tilly, David A. Sinclair
  • Publication number: 20180338991
    Abstract: Disclosed herein are novel compositions and methods for the treatment of age-related diseases, mitochondrial diseases, the improvement of stress resistance, the improvement of resistance to hypoxia and the extension of life span. Also described herein are methods for the identification of agents useful in the foregoing methods. Methods and compositions are provided for the treatment of diseases or disorders associated with mitochondrial dysfunction. The invention relates to methods for treatment and prevention of cancer by administering agents that increase levels of NAD+, such as NAD+ precursors or agents involved in NAD+ biosynthesis.
    Type: Application
    Filed: December 7, 2017
    Publication date: November 29, 2018
    Applicants: President and Fellows of Harvard College, NewSouth Innovations Pty Limited
    Inventors: David A. Sinclair, Ana P. Gomes, Lindsay Wu
  • Publication number: 20180322691
    Abstract: Systems, methods, and articles of manufacture for real-time rendering using compressed animated light fields are disclosed. One embodiment provides a pipeline, from offline rendering of an animated scene from sparse optimized viewpoints to real-time rendering of the scene with freedom of movement, that includes three stages: offline preparation and rendering, stream compression, and real-time decompression and reconstruction. During offline rendering, optimal placements for cameras in the scene are determined, and color and depth images are rendered using such cameras. Color and depth data is then compressed using an integrated spatial and temporal scheme permitting high performance on graphics processing units for virtual reality applications.
    Type: Application
    Filed: May 4, 2018
    Publication date: November 8, 2018
    Inventors: Kenneth J. MITCHELL, Charalampos KONIARIS, Malgorzata E. KOSEK, David A. SINCLAIR
  • Publication number: 20180312830
    Abstract: Provided herein are methods and compositions for the capture of nucleic acids, for example by using a nucleic acid-guided nuclease-based system.
    Type: Application
    Filed: August 18, 2016
    Publication date: November 1, 2018
    Applicant: Arc Bio, LLC
    Inventors: Stephane B. GOURGUECHON, Eric HARNESS, David SINCLAIR, Meredith L. CARPENTER
  • Publication number: 20180161256
    Abstract: Compositions allowing the stimulation of hyaluronic acid synthesis via an increase in has-2 expression and their use in the treatment of conditions related to a decrease in hyaluronic acid synthesis.
    Type: Application
    Filed: June 5, 2015
    Publication date: June 14, 2018
    Inventors: Bertrand THOMAS, Mathilde THOMAS, David SINCLAIR
  • Publication number: 20180163243
    Abstract: Enzyme-based systems and methods for synthesizing the NAD precursors NMN and NaMN are disclosed. Such methods and systems utilize a mutated form of phosphoribosylpyrophosphate synthetase (PRS) that is superactive and/or other enzyme or enzyme combinations that are immobilized onto a solid surface. The methods and systems substantially increase the efficiency and yield of NAD precursor synthesis.
    Type: Application
    Filed: December 11, 2017
    Publication date: June 14, 2018
    Inventors: Lindsay Wu, David A. Sinclair, Kyle Meetze
  • Publication number: 20180147227
    Abstract: The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for treating diseases and improving cell and tissue survival.
    Type: Application
    Filed: January 23, 2018
    Publication date: May 31, 2018
    Inventors: Karl D. Normington, David A. Sinclair, David J. Livingston, James M. Mckearin, Bruce Szczpankiewicz, Jonathan N. Kremsky
  • Publication number: 20180125871
    Abstract: Methods and compositions for preventing or treating peripheral neuropathy, cognitive deficits, inactivity, depression, chemotherapy and/or radiotherapy induced peripheral neuropathy and cognitive deficits, and improving cognitive performance, in a subject in need thereof are disclosed. The disclosed methods include the step of administering to the subject an effective amount of an agent that increases the level of NAD+ in the subject.
    Type: Application
    Filed: April 28, 2016
    Publication date: May 10, 2018
    Inventors: Lindsay Wu, David A. Sinclair
  • Publication number: 20180118819
    Abstract: Disclosed herein are novel compositions and methods for the treatment of age-related diseases, mitochondrial diseases, the improvement of stress resistance, the improvement of resistance to hypoxia and the extension of life span. Also described herein are methods for the identification of agents useful in the foregoing methods. Methods and compositions are provided for the treatment of diseases or disorders associated with mitochondrial dysfunction.
    Type: Application
    Filed: May 26, 2017
    Publication date: May 3, 2018
    Applicants: President and Fellows of Harvard College, Massachusetts Institute of Technology
    Inventors: David A. Sinclair, Ana P. Gomes, Eric Bell
  • Publication number: 20180100166
    Abstract: Compositions and methods comprising bioenergetic agents for restoring the quality of aged oocytes, enhancing oogonial stem cells or improving derivatives thereof (e.g., cytoplasm or isolated mitochondria) for use in fertility-enhancing procedures, are described.
    Type: Application
    Filed: November 17, 2017
    Publication date: April 12, 2018
    Inventors: Jonathan Lee Tilly, David A. Sinclair
  • Publication number: 20180085383
    Abstract: The invention provides methods and compositions for inhibiting CD38 activity, and methods of treating or preventing various disorders associated with CD38 activity.
    Type: Application
    Filed: May 9, 2017
    Publication date: March 29, 2018
    Inventors: David A. Sinclair, Nathan L. Price, Eduardo N. Chini, Jon C. Clardy, Shugeng Cao
  • Publication number: 20180089905
    Abstract: A method of rendering content items on a display via an electronic device involves mapping linked content items to a three-dimensional object defined by layout data. The layout data is then transmitted to an electronic device for display.
    Type: Application
    Filed: September 26, 2016
    Publication date: March 29, 2018
    Applicants: Disney Enterprises, Inc., ETH Zürich (Eidgenössische Technische Hochschule Zürich)
    Inventors: Barbara Solenthaler, Sohyeon Jeong, Max Grosse, Sasha Schriber, David Sinclair, Maria Cabral, Markus Gross, Kenneth J. Mitchell
  • Patent number: 9919003
    Abstract: The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for treating diseases and improving cell and tissue survival.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: March 20, 2018
    Assignee: Metro International Biotech, LLC
    Inventors: Karl D. Normington, David A. Sinclair, David J. Livingston, James M. McKearin, Bruce Szczpankiewicz, Jonathan N. Kremsky
  • Patent number: 9877981
    Abstract: Disclosed herein are novel compositions and methods for the treatment of age-related diseases, mitochondrial diseases, the improvement of stress resistance, the improvement of resistance to hypoxia and the extension of life span. Also described herein are methods for the identification of agents useful in the foregoing methods. Methods and compositions are provided for the treatment of diseases or disorders associated with mitochondrial dysfunction. The invention relates to methods for treatment and prevention of cancer by administering agents that increase levels of NAD+, such as NAD+ precursors or agents involved in NAD+ biosynthesis.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: January 30, 2018
    Assignees: President and Fellows of Harvard College, NewSouth Innovations Pty Limited
    Inventors: David A. Sinclair, Ana P. Gomes, Lindsay Wu